ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases. The company offers hepatic-targeted programs, including Agazisiran, a complement factor B (CFB) program that represents a pipeline-in-a-product opportunity, where a single therapeutic candidate has the potential to address multiple indications; Onvuzosiran, a clinical program for the prevention of HAE attacks; and ADX-626, a Factor XI (FXI) program for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation. It also offers extrahepatic-targeted programs, such as ADX-077, an adipose-targeted obesity program designed to reduce body weight and fat while preserving lean mass; and ADX-199, a neuron-targeted program designed to selectively silence and degrade amyloid-ß precursor protein (APP) mRNA in neurons, which is genetically linked to Alzheimer's disease. The company was incorporated in 2019 and is based in San Diego, California.
Frequently asked questions
What sector does ADARx Pharmaceuticals, Inc. Common Stock (ADRX) operate in?
ADARx Pharmaceuticals, Inc. Common Stock belongs to the Other sector and operates in the Biotechnology industry.
What is ADARx Pharmaceuticals, Inc. Common Stock (ADRX) current stock price?
As of the latest data, ADARx Pharmaceuticals, Inc. Common Stock stock price is $17.81, with a previous close of $17.63. ADARx Pharmaceuticals, Inc. Common Stock gained $0.18 in the last trading session, representing a 1.02% increase.
What is ADARx Pharmaceuticals, Inc. Common Stock (ADRX) current market capitalization?
ADARx Pharmaceuticals, Inc. Common Stock market cap is approximately 1.90 billion.
What is ADARx Pharmaceuticals, Inc. Common Stock (ADRX) Earnings Per Share (EPS)?
The trailing EPS is -$1.16.
What is ADARx Pharmaceuticals, Inc. Common Stock (ADRX) EBITDA?
ADARx Pharmaceuticals, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -29.16 million.
Does ADARx Pharmaceuticals, Inc. Common Stock (ADRX) pay dividends?
No. ADARx Pharmaceuticals, Inc. Common Stock does not pay a dividend.
What is ADARx Pharmaceuticals, Inc. Common Stock (ADRX) beta (volatility) score?
ADARx Pharmaceuticals, Inc. Common Stock has a beta of -0.004, indicating lower volatility than the overall market.
